Not logged inPrediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
Haeberle, Lothar; Erber, Ramona; Gass, Paul; Hein, Alexander; Niklos, Melitta; Volz, Bernhard; Hack, Carolin C.; Schulz-Wendtland, Ruediger; Huebner, Hanna; Goossens, Chloe; Christgen, Matthias; Doerk, Thilo; Park-Simon, Tjoung-Won; Schneeweiss, Andreas; Untch, Michael; Nekljudova, Valentina; Loibl, Sibylle; Hartmann, Arndt; Beckmann, Matthias W.; Fasching, Peter A. .png)
Share.png)
SaveMachine learning to predict treatment response and tolerability in HR+, HER2-advanced breast cancer: German study AI4ANNAFasching, Peter A.; Wockel, Achim; Tesch, Hans; Volz, Bernhard; Pritzsche, Uwe; Bachmann, Marc; Vodencarevic, Asmir; Kreuzeder, Julia; Luftner, Diana Share Save Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusHein, Alexander; Hartkopf, Andreas D.; Emons, Julius; Lux, Michael P.; Volz, Bernhard; Taran, Florin-Andrei; Overkamp, Friedrich; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lueftner, Diana; Wurmthaler, Lena A.; Wallwiener, Markus; Mueller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Kurbacher, Christian M.; Wuerstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Kolberg, Hans-Christian Share Save Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany (vol 54, pg 88, 2020)Schneeweiss, Andreas; Ettl, Johannes; Lueftner, Diana; Beckmann, Matthias W.; Belleville, Erik; Fasching, Peter A.; Fehm, Tanja N.; Geberth, Matthias; Haeberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D.; Hielscher, Carsten; Huober, Jens; Ruckhaeberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christian; Kurbacher, Christian M.; Klein, Evelyn; Lux, Michael P.; Mueller, Volkmar; Nabieva, Naiba; Overkamp, Friedrich; Tesch, Hans; Laakmann, Elena; Taran, Florin-Andrei; Seitz, Julia; Thomssen, Christoph; Untch, Michael; Wimberger, Pauline; Wuerstlein, Rachel; Volz, Bernhard; Wallwiener, Diethelm; Wallwiener, Markus; Brucker, Sara Y. Share Save Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in GermanySchneeweiss, Andreas; Ettl, Johannes; Lueftner, Diana; Beckmann, Matthias W.; Belleville, Erik; Fasching, Peter A.; Fehm, Tanja N.; Geberth, Matthias; Haberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D.; Hielscher, Carsten; Huober, Jens; Ruckhaberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christian; Kurbacher, Christian M.; Klein, Evelyn; Lux, Michael P.; Mueller, Volkmar; Nabieva, Naiba; Overkamp, Friedrich; Tesch, Hans; Laakmann, Elena; Taran, Florin-Andrei; Seitz, Julia; Thomssen, Christoph; Untch, Michael; Wimberger, Pauline; Wuerstlein, Rachel; Volz, Bernhard; Wallwiener, Diethelm; Wallwiener, Markus; Brucker, Sara Y. Share Save Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in GermanyHuebner, Hanna; Kurbacher, Christian M.; Kuesters, Geoffrey; Hartkopf, Andreas D.; Lux, Michael P.; Huober, Jens; Volz, Bernhard; Taran, Florin-Andrei; Overkamp, Friedrich; Tesch, Hans; Haeberle, Lothar; Lueftner, Diana; Wallwiener, Markus; Mueller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Ruebner, Matthias; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Kolberg, Hans-Christian; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Ettl, Johannes Share Save Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor αIngle, James N.; Cairns, Junmei; Suman, Vera J.; Shepherd, Lois E.; Fasching, Peter A.; Hoskin, Tanya L.; Singh, Ravinder J.; Desta, Zeruesenay; Kalari, Krishna R.; Ellis, Matthew J.; Goss, Paul E.; Chen, Bingshu E.; Volz, Bernhard; Barman, Poulami; Carlson, Erin E.; Haddad, Tufia; Goetz, Matthew P.; Goodnature, Barbara; Cuellar, Matthew E.; Walters, Michael A.; Correia, Cristina; Kaufmann, Scott H.; Weinshilboum, Richard M.; Wang, Liewei Share Save Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsHack, C. C.; Haeberle, L.; Brucker, S. Y.; Janni, W.; Volz, B.; Loehberg, C. R.; Hartkopf, A. D.; Walter, C-B; Baake, G.; Fridman, A.; Malter, W.; Wuerstlein, R.; Harbeck, N.; Hoffmann, O.; Kuemmel, S.; Martin, B.; Thomssen, C.; Graf, H.; Wolf, C.; Lux, M. P.; Bayer, C. M.; Rauh, C.; Almstedt, K.; Gass, P.; Heindl, F.; Brodkorb, T.; Willer, L.; Lindner, C.; Kolberg, H-C; Krabisch, P.; Weigel, M.; Steinfeld-Birg, D.; Kohls, A.; Brucker, C.; Schulz, V; Fischer, G.; Pelzer, V; Rack, B.; Beckmann, M. W.; Fehm, T.; Rody, A.; Maass, N.; Hein, A.; Fasching, P. A.; Nabieva, N. Share Save Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patientsNabieva, Naiba; Haeberle, Lothar; Brucker, Sara Y.; Janni, Wolfgang; Volz, Bernhard; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina-Barbara; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kuemmel, Sherko; Martin, Bernhard; Thomssen, Christoph; Graf, Heiko; Wolf, Christopher; Lux, Michael P.; Bayer, Christian M.; Rauh, Claudia; Hack, Carotin C.; Almstedt, Katrin; Gass, Paul; Heindl, Felix; Brodkorb, Tobias; Lindner, Christoph; Kolberg, Hans-Christian; Krabisch, Petra; Weigel, Michael; Steinfeld-Birg, Dieter; Kohls, Andreas; Brucker, Cosima; Schulz, Volker; Fischer, Gunnar; Pelzer, Volker; Rack, Brigitte; Beckmann, Matthias W.; Fehm, Tanja; Rody, Achim; Maass, Nicolai; Hein, Alexander; Fasching, Peter A. Share Save Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancerFasching, Peter A.; Gass, Paul; Haeberle, Lothar; Volz, Bernhard; Hein, Alexander; Hack, Carolin C.; Lux, Michael P.; Jud, Sebastian M.; Hartmann, Arndt; Beckmann, Matthias W.; Slamon, Dennis J.; Erber, Ramona Share Save Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167)Schneeweiss, A.; Lux, M. P.; Hartkopf, A. D.; Volz, B.; Kolberg, H-C; Hadji, P.; Tesch, H.; Haeberle, L.; Ettl, J.; Lueftner, D. I.; Wallwiener, M.; Mueller, V.; Beckmann, M. W.; Belleville, E.; Wimberger, P.; Hielscher, C.; Geberth, M.; Lermann, J.; Abenhardt, W.; Kurbacher, C.; Wuerstlein, R.; Thomssen, C.; Untch, M.; Overkamp, F.; Huober, J.; Taran, F-A; Janni, W.; Wallwiener, D.; Brucker, S. Y.; Fasching, P. A.; Fehm, T. N. Share Save Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167)Lux, M. P.; Hartkopf, A. D.; Huober, J.; Volz, B.; Taran, F-A; Overkamp, F.; Hadji, P.; Tesch, H.; Haeberle, L.; Ettl, J.; Lueftner, D. I.; Wallwiener, M.; Mueller, V.; Beckmann, Mw; Belleville, E.; Wimberger, P.; Hielscher, C.; Geberth, M.; Lermann, J.; Abenhardt, W.; Kurbacher, C.; Wuerstlein, R.; Thomssen, C.; Untch, M.; Fasching, P. A.; Janni, W.; Fehm, T. N.; Wallwiener, D.; Brucker, S. Y.; Schneeweiss, A.; Kolberg, H-C Share Save Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxelFasching, P. A.; Eggemann, H.; Krocker, J.; Haeberle, L.; Volz, B.; Kleine-Tebbe, A.; Blohmer, J-U; Kittel, K.; Hufnagel, M.; Janni, W.; Emons, G.; Simon, E.; Koehler, U.; Thomssen, C.; Kohls, A.; Beckmann, M. W.; Hielscher, C.; Krabisch, P.; Zeiser, T.; Brodkorb, T.; Baier, F.; Nabieva, N.; Kellner, S.; Untch, M.; Stadie, S.; Budner, M.; Breitbach, G-P; Keller, M.; Stickeler, E.; Kuehn, T.; Tolkmitt, M.; Belau, A. K.; Schmidt, M.; Ulm, K.; Kuemmel, S. Share Save PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/metastatic setting (NCT02338167)Mueller, V.; Huober, J.; Volz, B.; Overkamp, F.; Kolberg, H-C; Hadji, P.; Haeberle, L.; Ettl, J.; Hartkopf, A. D.; Lux, M. P.; Lueftner, D. I.; Wallwiener, M.; Taran, F-A; Beckmann, M. W.; Belleville, E.; Wimberger, P.; Hielscher, C.; Geberth, M.; Lermann, J.; Abenhardt, A.; Kurbacher, C.; Wuerstlein, R.; Thomssen, C.; Untch, M.; Janni, W.; Fehm, T. N.; Brucker, S. Y.; Wallwiener, D.; Schneeweiss, A.; Fasching, P. A.; Tesch, H. Share Save Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancerWunderle, Marius; Pretscher, Jutta; Brucker, Sara Y.; Volz, Bernhard; Hartmann, Arndt; Fiessler, Cornelia; Hein, Alexander; Haeberle, Lothar; Jud, Sebastian M.; Lux, Michael P.; Janni, Wolfgang; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina B.; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kuemmel, Sherko; Martin, Bernhard; Thomssen, Christoph; Graf, Heiko; Wolf, Christopher; Bayer, Christian M.; Hack, Carolin C.; Almstedt, Katrin; Gass, Paul; Heindl, Felix; Brodkorb, Tobias F.; Nabieva, Naiba; Lindner, Christoph; Kolberg, Hans-Christian; Krabisch, Petra; Weigel, Michael; Steinfeld-Birg, Dieter; Kohls, Andreas; Brucker, Cosima; Schulz, Volker; Fischer, Gunnar; Pelzer, Volker; Wallwiener, Diethelm; Rack, Brigitte; Fehm, Tanja; Rody, Achim; Maass, Nicolai; Beckmann, Matthias W.; Fasching, Peter A.; Rauh, Claudia Share Save Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysisFasching, Peter A.; Hartkopf, Andreas D.; Gass, Paul; Haeberle, Lothar; Akpolat-Basci, Leyla; Hein, Alexander; Volz, Bernhard; Taran, Florin-Andrei; Nabieva, Naiba; Pott, Birgit; Overkamp, Friedrich; Einarson, Hanna; Hadji, Peyman; Tesch, Hans; Ettl, Johannes; Lueftner, Diana; Wallwiener, Markus; Mueller, Volkmar; Janni, Wolfgang; Fehm, Tanja N.; Schneeweiss, Andreas; Untch, Michael; Pott, Dirk; Lux, Michael P.; Geyer, Thomas; Liedtke, Cornelia; Seeger, Harald; Wetzig, Sarah; Hartmann, Arndt; Schulz-Wendtland, Ruediger; Belleville, Erik; Wallwiener, Diethelm; Beckmann, Matthias W.; Brucker, Sara Y.; Kolberg, Hans-Christian Share Save Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patientsHuebner, Hanna; Fasching, Peter A.; Gumbrecht, Walter; Jud, Sebastian; Rauh, Claudia; Matzas, Mark; Paulicka, Peter; Friedrich, Katja; Lux, Michael P.; Volz, Bernhard; Gass, Paul; Haeberle, Lothar; Meier-Stiegen, Franziska; Hartkopf, Andreas; Neubauer, Hans; Almstedt, Katrin; Beckmann, Matthias W.; Fehm, Tanja N.; Ruebner, Matthias Share Save Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registryMueller, Volkmar; Nabieva, Naiba; Haeberle, Lothar; Taran, Florin-Andrei; Hartkopf, Andreas D.; Volz, Bernhard; Overkamp, Friedrich; Brandl, Anna Lisa; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Ettl, Johannes; Lux, Michael P.; Lueftner, Diana; Belleville, Erik; Fasching, Peter A.; Janni, Wolfgang; Beckmann, Matthias W.; Wimberger, Pauline; Hielscher, Carsten; Fehm, Tanja N.; Brucker, Sara Y.; Wallwiener, Diethelm; Schneeweiss, Andreas; Wallwiener, Markus Share Save Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registryHartkopf, Andreas D.; Huober, Jens; Volz, Bernhard; Nabieva, Naiba; Taran, Florin-Andrei; Schwitulla, Judith; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lux, Michael P.; Lueftner, Diana; Wallwiener, Markus; Mueller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Geberth, Matthias; Fersis, Nikos; Abenhardt, Wolfgang; Kurbacher, Christian; Wuerstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
BREAST.png)
OAAI